Skip to main content
Cynthia Wetmore, MD, Pediatrics, Duluth, MN

CynthiaJWetmoreMDPhD

Pediatrics Duluth, MN

Hospitalist, Pediatric Healthcare Research and Healthcare Policy, Pediatric Hematology/Oncology

Hospitalist, St. Luke's Hospital Duluth, MN

Dr. Wetmore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wetmore's full profile

Already have an account?

  • Office

    Pediatric Hospital Medicine
    Duluth, MN 55805

Summary

  • Dr. Cynthia Wetmore is a pediatric hospitalist and is affiliated with St. Luke's Hospital in Duluth, MN. She received her medical degree from University of Minnesota Medical School and has been in practice 22 years. In addition to the practice of hospital medicine, she specializes in pediatric hematology-oncology and is experienced in pediatric neuro-oncology, clincial trials, quality improvement and translational research.

Clinical Expertise

  • Oncology, Pediatric neuro-oncology, Clincial trials, Translational Research

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Pediatrics, 2001 - 2002
  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology, 1997 - 2001
  • University of Minnesota
    University of MinnesotaResidency, Pediatrics, 1995 - 1997
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1995
  • Karolinska Institutet
    Karolinska InstitutetPhD, Histology and Neurobiology, 1992
  • Harvard University
    Harvard UniversityB.A., History of Science, Magna Cum Laude, 1986

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2017 - 2026
  • CA State Medical License
    CA State Medical License 2021 - 2025
  • MN State Medical License
    MN State Medical License 2001 - 2025
  • MS State Medical License
    MS State Medical License 2022 - 2024
  • GA State Medical License
    GA State Medical License 2014 - 2020
  • TN State Medical License
    TN State Medical License 2010 - 2014
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Award for basic/translational science International Society for Pediatric Oncology (SIOP), 2007
  • Distinguished Scientist Award Sontag Foundation, 2004
  • Award for Excellence in Teaching Mayo College of Medicine, 2003
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase I trial, pharmacokinetics and pharmacodynamics of vandetanib and dasatanib in children with newly diagnosed diffuse intrinsic pontine glioma  
    Broniscer A, Baker SD, Wetmore C, Pai-Panandiker A, Huang J, Davidoff AM, Onar-Thomas A, Panetta JC, Chin TK, Merchant TE, Baker JN, Kaste SC, Gajjar A, Stewart CF, Clin Cancer Res, 1/27/2013
  • Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)  
    Roberts MS, Turner DC, Owens TS, Ramachandran A, Wetmore C, Throm SL, Stewart CF, J Chromatogr B Analyt Technol Biomed Life Sci, 1/15/2013
  • Diffuse leptomemingeal gliomatosis  
    Jicha GA, Glantz J, Clarke MJ, Lehwald LM Russo DP, Giannini C, Wald JT, Uhm J, Kumar N, Aksamit AJ, Wetmore CJ, Eur Neurol, 1/1/2009
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • First in Pediatrics Phase I study of crenolanib (CP-868,596) administered during and after radiation therapy (RT) in newly-diagnosed diffuse intrinsic pontine glioma (...
    Wetmore, C., Broniscer, A., Wright, K., Armstrong, G., Baker, J., Kun, L., Patay, Z., Onar-Thomas, A., Ramachandran, A., Turner, D., Gajjar, A., Stewart, C, ASCO Annual Meeting, Chicago, IL, 1/1/2014
  • Activity of alisertib (MLN8237) as single agent in recurrent atypical teratiod tumor (ATRT) in four children: a single patient treatment plan pilot study.
    Wetmore C, Bendel A, Gajjar A, Rhabdoid Tumors: Integrating biological insights with clinical successes. Institut Curie, Paris, France, 1/1/2013
  • A Phase I trial of MK-0752 in Pediatric Patients with Recurrent or Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study.
    M. Fouladi, J. Olson, C.F. Stewart, M. Kocak, A. Onar-Thomas, L. Wagner, R. J. Packer, S. Goldman, S. Gururangan, S. M. Blaney, I. Pollack, C. Smith, A. Gajjar, T. Dem..., SNO Annual Meeting, 1/1/2013
  • Join now to see all

Lectures

  • Research 101: Tissue acquisition and Bio-banking. 
    1/1/2014
  • The Cancer Answer: Progress and Possibilities 
    Woodruff Arts Center, Atlanta, GA - 1/1/2014
  • PDGFR signaling in diffuse pontine glioma. 
    Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY - 1/1/2013
  • Join now to see all

Press Mentions

  • Examining COVID’s Impact on Clinical Research Participant Diversity
    Examining COVID’s Impact on Clinical Research Participant DiversityFebruary 21st, 2022
  • Fertility Preservation for Pediatric and Adolescent Patients with Cancer: Medical and Ethical Considerations
    Fertility Preservation for Pediatric and Adolescent Patients with Cancer: Medical and Ethical ConsiderationsMarch 2nd, 2020
  • Gilbert Girl, 7, Takes on Battle for Her Life
    Gilbert Girl, 7, Takes on Battle for Her LifeSeptember 6th, 2019
  • Join now to see all

Professional Memberships